Enhancing Healthcare Access-Smartphone Apps in Arrhythmia Screening: Viewpoint.
Marcin KsiążczykAgnieszka Dębska-KozłowskaIzabela WarchołAndrzej LubińskiPublished in: JMIR mHealth and uHealth (2021)
Atrial fibrillation is the most commonly reported arrhythmia and, if undiagnosed or untreated, may lead to thromboembolic events. It is therefore desirable to provide screening to patients in order to detect atrial arrhythmias. Specific mobile apps and accessory devices, such as smartphones and smartwatches, may play a significant role in monitoring heart rhythm in populations at high risk of arrhythmia. These apps are becoming increasingly common among patients and professionals as a part of mobile health. The rapid development of mobile health solutions may revolutionize approaches to arrhythmia screening. In this viewpoint paper, we assess the availability of smartphone and smartwatch apps and evaluate their efficacy for monitoring heart rhythm and arrhythmia detection. The findings obtained so far suggest they are on the right track to improving the efficacy of early detection of atrial fibrillation, thus lowering the risk of stroke and reducing the economic burden placed on public health.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- left atrial appendage
- oral anticoagulants
- public health
- direct oral anticoagulants
- heart failure
- healthcare
- end stage renal disease
- chronic kidney disease
- ejection fraction
- percutaneous coronary intervention
- newly diagnosed
- loop mediated isothermal amplification
- peritoneal dialysis
- prognostic factors
- brain injury
- left ventricular
- cerebral ischemia
- acute coronary syndrome